Sponsors (16)
The bill trades clearer, safety‑focused federal oversight and regulatory certainty for cell‑cultivated proteins—improving consumer protection and market clarity—against higher compliance costs, potential short‑term market delays, and added enforcement burden that could particularly strain small producers and regulators.
Consumers nationwide will get clearer, unified federal safety oversight and inspections for cell‑cultivated protein products because the bill assigns joint FDA–USDA roles and applies existing meat/poultry inspection statutes to these products.
Producers and small food businesses will gain regulatory certainty—through defined FDA and USDA responsibilities and mandatory standards of identity within 180 days—making it easier and faster to bring cell‑cultivated products to market.
Consumers and manufacturers will benefit from premarket consultation and current Good Manufacturing Practice (cGMP) requirements that reduce contamination and unsafe inputs in cultured foods.
Small producers and food manufacturers will face new and potentially substantial compliance costs (premarket reviews, cell‑bank and facility requirements, inspections, and labeling), which could raise prices or drive some small firms out of the market.
Federal agencies (USDA and FDA), and potentially state regulators, will incur increased administrative and enforcement burdens and transitional complexity, likely requiring more resources or diverting staff from other duties.
Some cell‑cultivated products could face longer premarket review timelines and tighter oversight, delaying market entry and limiting consumer choices in the short term.
Based on analysis of 3 sections of legislative text.
Creates definitions and mandatory labeling for cell‑cultivated and plant‑based alternative proteins, assigns agency oversight duties, and applies meat/poultry inspection rules to cell‑cultivated products.
Introduced April 30, 2026 by Mark Alford · Last progress April 30, 2026
Requires USDA and HHS/FDA to update their agreement and regulatory roles for cell‑cultivated animal protein, and sets new definitions, labeling rules, and inspection parity for cell‑cultivated meat and poultry and for plant‑based alternative protein products. Agencies must revise an existing Memorandum of Understanding within 90 days and develop common standards of identity within 180 days. Makes cell‑cultivated meat and poultry subject to the same inspection and many legal requirements as conventional meat and poultry, assigns specific premarket and manufacturing oversight duties to FDA/HHS and implementation and enforcement duties to USDA, and requires on‑package labels that clearly identify products as cell‑cultivated or plant‑based alternatives and state they are not naturally produced meat or poultry.